PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cancer 1,053,491 Disease Target EPHB3 118 25 0.00 -0.89 0.21 0.56
Cancer 1,053,491 Disease Target Annexin A1 406 86 0.00 -0.89 0.21 0.57
Cancer 1,053,491 Disease Target CD137 474 102 0.00 -0.89 0.22 0.57
Cancer 1,053,491 Disease Target Multidrug Resistance-Associated Protein 2 462 100 0.00 -0.89 0.22 0.57
Cancer 1,053,491 Disease Disease Nausea 42,627 9,149 0.04 -0.88 0.21 0.62
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target DAPK2 27 6 0.00 -0.88 0.22 0.56
Cancer 1,053,491 Disease Target Cytokeratin 18 1,108 249 0.01 -0.88 0.22 0.58
Cancer 1,053,491 Disease Target BMPR1A 279 63 0.00 -0.88 0.23 0.57
Cancer 1,053,491 Disease Disease Glioblastoma 17,933 4,092 0.03 -0.88 0.23 0.61
Cancer 1,053,491 Disease Target DNA-damage-inducible transcript 3 30 7 0.00 -0.88 0.23 0.56
Cancer 1,053,491 Disease Target Cox-2 21,583 5,031 0.03 -0.87 0.23 0.61
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Cancer 1,053,491 Disease Disease Mesothelioma 11,198 2,734 0.03 -0.87 0.24 0.60
Cancer 1,053,491 Disease Disease Xerostomia 3,054 759 0.01 -0.87 0.25 0.59
Cancer 1,053,491 Disease Drug Acarbose (Precose)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Ancobon (Flucytosine)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Ck-beta-11 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Drug Alemtuzumab (Campath)- FDA 32 8 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target EPHB2 385 97 0.00 -0.86 0.25 0.57
Cancer 1,053,491 Disease Disease Asthenia 3,478 877 0.01 -0.86 0.25 0.59
Cancer 1,053,491 Disease Drug Azacitidine (Vidaza)- FDA 47 12 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Target CYR61 539 138 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Target AXL 633 165 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Target ACVR1B 23 6 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Disease Basal Cell Carcinoma 7,953 2,086 0.02 -0.86 0.26 0.60
Cancer 1,053,491 Disease Disease Benign Prostatic Hyperplasia 10,026 2,638 0.03 -0.86 0.26 0.61
Cancer 1,053,491 Disease Target Glutathione S-Transferase A3 15 4 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Target Collapsin Response Mediator Protein-1 30 8 0.00 -0.86 0.27 0.56
Cancer 1,053,491 Disease Target ERBB4 994 273 0.01 -0.85 0.27 0.58
Cancer 1,053,491 Disease Target Cytokeratin 8 587 162 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 257 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target Ret Proto-Oncogene 1,005 281 0.01 -0.85 0.28 0.58
Cancer 1,053,491 Disease Target CCN5 57 16 0.00 -0.85 0.28 0.56
Cancer 1,053,491 Disease Target AP2M1 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Drug Amaryl (Glimepiride)- FDA 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target CXCL14/BRAK 7 2 0.00 -0.85 0.29 0.56
Cancer 1,053,491 Disease Target EPHB4 329 94 0.01 -0.85 0.29 0.58
Cancer 1,053,491 Disease Target beta-Cellulin 17 5 0.00 -0.84 0.29 0.56
Cancer 1,053,491 Disease Target CAPG 85 25 0.00 -0.84 0.29 0.57
Cancer 1,053,491 Disease Target BRK 236 70 0.00 -0.84 0.30 0.57
Cancer 1,053,491 Disease Target Urokinase-Type Plasminogen Activator 3,939 1,166 0.02 -0.84 0.30 0.60
Cancer 1,053,491 Disease Drug Drometrizole 10 3 0.00 -0.84 0.30 0.56